AU673882B2 - Antioxidant neuroprotective use of, and method of treatment using, hydroxycarbazole compounds - Google Patents

Antioxidant neuroprotective use of, and method of treatment using, hydroxycarbazole compounds

Info

Publication number
AU673882B2
AU673882B2 AU57323/94A AU5732394A AU673882B2 AU 673882 B2 AU673882 B2 AU 673882B2 AU 57323/94 A AU57323/94 A AU 57323/94A AU 5732394 A AU5732394 A AU 5732394A AU 673882 B2 AU673882 B2 AU 673882B2
Authority
AU
Australia
Prior art keywords
carbon atoms
formula
hydrogen
compound
lower alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU57323/94A
Other languages
English (en)
Other versions
AU5732394A (en
Inventor
Frank C Barone
Hung-Yuan Cheng
Giora Feuerstein
Paul G. Lysko
Tian-Li Yue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU5732394A publication Critical patent/AU5732394A/en
Application granted granted Critical
Publication of AU673882B2 publication Critical patent/AU673882B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU57323/94A 1992-12-01 1993-12-01 Antioxidant neuroprotective use of, and method of treatment using, hydroxycarbazole compounds Ceased AU673882B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US98392092A 1992-12-01 1992-12-01
US983920 1992-12-01
PCT/US1993/011598 WO1994012178A1 (en) 1992-12-01 1993-12-01 Antioxidant neuroprotective use of, and method of treatment using, hydroxycarbazole compounds

Publications (2)

Publication Number Publication Date
AU5732394A AU5732394A (en) 1994-06-22
AU673882B2 true AU673882B2 (en) 1996-11-28

Family

ID=25530181

Family Applications (1)

Application Number Title Priority Date Filing Date
AU57323/94A Ceased AU673882B2 (en) 1992-12-01 1993-12-01 Antioxidant neuroprotective use of, and method of treatment using, hydroxycarbazole compounds

Country Status (8)

Country Link
EP (1) EP0671914A1 (enrdf_load_stackoverflow)
JP (1) JPH08503711A (enrdf_load_stackoverflow)
KR (1) KR950703950A (enrdf_load_stackoverflow)
CN (1) CN1042795C (enrdf_load_stackoverflow)
AU (1) AU673882B2 (enrdf_load_stackoverflow)
CA (1) CA2150695A1 (enrdf_load_stackoverflow)
WO (1) WO1994012178A1 (enrdf_load_stackoverflow)
ZA (1) ZA938897B (enrdf_load_stackoverflow)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997040680A1 (en) * 1996-04-29 1997-11-06 Smithkline Beecham Corporation Antioxidant compound
EP0910374A1 (de) * 1996-07-13 1999-04-28 Roche Diagnostics GmbH Topisch einsetzbare pharmazeutische formulierungen enthaltend als wirkstoff ein carbazolyl-(4)-oxy-propanolamin-derivat
US6369106B1 (en) * 1996-12-26 2002-04-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Treatment of ischemic brain injuries with brain targeted anti oxidant compounds
JPH10251147A (ja) * 1997-03-06 1998-09-22 Akira Matsumori 炎症性疾患の予防・治療剤
AR035455A1 (es) * 2001-04-23 2004-05-26 Hoffmann La Roche Derivados triciclicos de alquilhidroxamato , procesos para su elaboracion, composiciones farmaceuticas que los contienen, y el uso de dichos compuestos en la preparacion de medicamentos

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2815926A1 (de) * 1978-04-13 1979-10-18 Boehringer Mannheim Gmbh Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
CN1098908A (zh) 1995-02-22
JPH08503711A (ja) 1996-04-23
CA2150695A1 (en) 1994-06-09
KR950703950A (ko) 1995-11-17
ZA938897B (en) 1994-08-01
WO1994012178A1 (en) 1994-06-09
AU5732394A (en) 1994-06-22
EP0671914A4 (enrdf_load_stackoverflow) 1995-10-25
EP0671914A1 (en) 1995-09-20
CN1042795C (zh) 1999-04-07

Similar Documents

Publication Publication Date Title
AU675481B2 (en) Antioxydant cardioprotective use of, and method of treatmentusing, hydroxycarbazole compounds
JP4021507B2 (ja) プロリン含有医薬組成物
JPH07108855B2 (ja) 循環器治療薬として有用な酸化窒素―第一級アミン安定化コンプレックス
US5512572A (en) Anti-ischemic medicament
JP2852608B2 (ja) 口腔乾燥症治療剤
JP2002537258A5 (enrdf_load_stackoverflow)
CA2524034A1 (en) Uses of ion channel modulating compounds
HUE034007T2 (en) Treatment of atrial fibrillation
US20010011099A1 (en) Antioxidant neuroprotective use of, and method of treatment using, hydroxycarbazole compounds
AU673882B2 (en) Antioxidant neuroprotective use of, and method of treatment using, hydroxycarbazole compounds
EP1006793B1 (en) Anti-arrhythmic composition and methods of treatment
US5508308A (en) Use of pyruvylglycine to treat ischemia/reperfusion injury following myocardial infarction
EP0907318A1 (en) Antioxidant compound
IE900306A1 (en) Agent for use in the prevention, control or reversal of¹hypertension
HU208004B (en) Process for producing ascorbinic acid derivatives and pharmaceutical compositions containing them
GB2189703A (en) Vinpocetine
WO2010058779A1 (ja) ピリジン－３－カルバルデヒド ｏ－（ピペリジン－１－イル－プロピル）－オキシム誘導体を有効成分として含有する網脈絡膜変性疾患の治療剤
JPH0576925B2 (enrdf_load_stackoverflow)
HU211747A9 (en) Drugs containing verapamil and trandolapril
CA1256031A (en) Pharmaceutical compositions containing diltiazem and alfuzosin
US4716177A (en) Tolrestat for inhibition of weight gain
Mayrleitner E047/1
JPS6231689B2 (enrdf_load_stackoverflow)
HUP9903498A2 (hu) Kettős nemszelektív béta-adrenoceptor és alfa1-adrenoceptor antagonisták alkalmazása stressz-aktivált proteinkinázok gátlására szolgáló gyógyszerkészítmények előállítására